To the full analysis
Genpact stock: growth
GGenpact reported $5.08B in revenue for fiscal 2025, up 6.6% on the prior year, up 6.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
11.8%
per year from 2006 to 2025, per share 3.3%
Earnings (Annual rate)
14.9%
per year from 2006 to 2025, per share 6.2%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 6.5% | 7.5% | 11.8% |
| Revenue per share | 8.4% | 9.9% | 3.3% |
| Earnings | 12.4% | 8.7% | 14.9% |
| Earnings per share | 14.4% | 11.1% | 6.2% |
| Free cash flow | 7.4% | 10.7% | no data |
| Free cash flow per share | 9.4% | 13.2% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $613.05M | $39.77M | −$42.65M |
| 2007 | $822.68M | $56.42M | $84.09M |
| 2008 | $1.04B | $125.14M | $141.8M |
| 2009 | $1.12B | $127.3M | $105.63M |
| 2010 | $1.26B | $142.18M | $107.93M |
| 2011 | $1.6B | $184.29M | $230.84M |
| 2012 | $1.9B | $184.59M | $227.32M |
| 2013 | $2.13B | $235.05M | $262.73M |
| 2014 | $2.28B | $192.17M | $209.26M |
| 2015 | $2.46B | $239.82M | $265.27M |
| 2016 | $2.57B | $267.55M | $257M |
| 2017 | $2.74B | $260.84M | $285.41M |
| 2018 | $3B | $281.26M | $179.09M |
| 2019 | $3.52B | $304.88M | $319.13M |
| 2020 | $3.71B | $308.28M | $513.52M |
| 2021 | $4.02B | $369.45M | $637.03M |
| 2022 | $4.37B | $353.4M | $389.28M |
| 2023 | $4.48B | $631.26M | $432.04M |
| 2024 | $4.77B | $513.67M | $530.19M |
| 2025 | $5.08B | $552.49M | $734.65M |
Revenue by region
Where Genpact Limited generates its revenue.
- India59%
- Asia Other Than India16%
- Americas14%
- Europe11%
Figures as a table
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|
| India | $1.89B | $1.85B | $2.02B | $2.28B | $2.32B | $2.76B | $2.98B | 58.7% |
| Asia Other Than India | $356.73M | $461.84M | $536.6M | $551.47M | $643.1M | $700.26M | $788.06M | 15.5% |
| Americas | $863.75M | $1.01B | $1.01B | $1.07B | $979.95M | $683.41M | $730.44M | 14.4% |
| Europe | $409.17M | $388.56M | $451.73M | $471.48M | $532.99M | $621.92M | $578.4M | 11.4% |
| Total revenue | $3.52B | $3.71B | $4.02B | $4.37B | $4.48B | $4.77B | $5.08B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 9 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.